▶ 調査レポート

世界の子宮肉腫の治療市場：市場規模・現状・予測
• 英文タイトル：Global Uterine Sarcoma Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の子宮肉腫の治療市場：市場規模・現状・予測 / Global Uterine Sarcoma Treatment Market Size, Status and Forecast 2019-2025 / QYR9N8163資料のイメージです。• レポートコード：QYR9N8163
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、子宮肉腫の治療のグローバル市場について調査・分析したレポートで、種類別（手術、放射線療法、ホルモン療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・子宮肉腫の治療の世界市場規模
・主要企業別市場シェア
・子宮肉腫の治療の世界市場規模：種類別（手術、放射線療法、ホルモン療法）
・子宮肉腫の治療の世界市場規模：用途別（病院、診療所、その他）
・子宮肉腫の治療のアメリカ市場規模（種類別、用途別）
・子宮肉腫の治療のヨーロッパ市場規模（種類別、用途別）
・子宮肉腫の治療の中国市場規模（種類別、用途別）
・子宮肉腫の治療の日本市場規模（種類別、用途別）
・子宮肉腫の治療の東南アジア市場規模（種類別、用途別）
・子宮肉腫の治療のインド市場規模（種類別、用途別）
・子宮肉腫の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・子宮肉腫の治療の世界市場予測（2019年-2025年）
・子宮肉腫の治療の地域別市場予測（2019年-2025年）
...

Sarcomas are the tumours of the mesenchymal tissues like bone, muscle, connective tissue, cartilage and fat. Uterine sarcoma is a rare type of cancer which starts in the muscle and supporting tissues of the uterus. Exposure to the X-rays increases the risk for uterine sarcoma.In 2018, the global Uterine Sarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Uterine Sarcoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Uterine Sarcoma Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Johnson & Johnson
General Electric
Koninklijke Philips
Siemens Healthcare
Intas Pharmaceuticals
Sun Pharmaceutical
…

Market segment by Type, the product can be split into
Surgery
Radiation Therapy
Hormone Therapy

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Uterine Sarcoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Uterine Sarcoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Uterine Sarcoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Uterine Sarcoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Hormone Therapy
1.5 Market by Application
1.5.1 Global Uterine Sarcoma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Uterine Sarcoma Treatment Market Size
2.2 Uterine Sarcoma Treatment Growth Trends by Regions
2.2.1 Uterine Sarcoma Treatment Market Size by Regions (2014-2025)
2.2.2 Uterine Sarcoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Uterine Sarcoma Treatment Market Size by Manufacturers
3.1.1 Global Uterine Sarcoma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Uterine Sarcoma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Uterine Sarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Uterine Sarcoma Treatment Key Players Head office and Area Served
3.3 Key Players Uterine Sarcoma Treatment Product/Solution/Service
3.4 Date of Enter into Uterine Sarcoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Uterine Sarcoma Treatment Market Size by Type (2014-2019)
4.2 Global Uterine Sarcoma Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Uterine Sarcoma Treatment Market Size (2014-2019)
5.2 Uterine Sarcoma Treatment Key Players in United States
5.3 United States Uterine Sarcoma Treatment Market Size by Type
5.4 United States Uterine Sarcoma Treatment Market Size by Application

6 Europe
6.1 Europe Uterine Sarcoma Treatment Market Size (2014-2019)
6.2 Uterine Sarcoma Treatment Key Players in Europe
6.3 Europe Uterine Sarcoma Treatment Market Size by Type
6.4 Europe Uterine Sarcoma Treatment Market Size by Application

7 China
7.1 China Uterine Sarcoma Treatment Market Size (2014-2019)
7.2 Uterine Sarcoma Treatment Key Players in China
7.3 China Uterine Sarcoma Treatment Market Size by Type
7.4 China Uterine Sarcoma Treatment Market Size by Application

8 Japan
8.1 Japan Uterine Sarcoma Treatment Market Size (2014-2019)
8.2 Uterine Sarcoma Treatment Key Players in Japan
8.3 Japan Uterine Sarcoma Treatment Market Size by Type
8.4 Japan Uterine Sarcoma Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Uterine Sarcoma Treatment Market Size (2014-2019)
9.2 Uterine Sarcoma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Uterine Sarcoma Treatment Market Size by Type
9.4 Southeast Asia Uterine Sarcoma Treatment Market Size by Application

10 India
10.1 India Uterine Sarcoma Treatment Market Size (2014-2019)
10.2 Uterine Sarcoma Treatment Key Players in India
10.3 India Uterine Sarcoma Treatment Market Size by Type
10.4 India Uterine Sarcoma Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Uterine Sarcoma Treatment Market Size (2014-2019)
11.2 Uterine Sarcoma Treatment Key Players in Central & South America
11.3 Central & South America Uterine Sarcoma Treatment Market Size by Type
11.4 Central & South America Uterine Sarcoma Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Uterine Sarcoma Treatment Introduction
12.1.4 Pfizer Revenue in Uterine Sarcoma Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Uterine Sarcoma Treatment Introduction
12.2.4 Johnson & Johnson Revenue in Uterine Sarcoma Treatment Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 General Electric
12.3.1 General Electric Company Details
12.3.2 Company Description and Business Overview
12.3.3 Uterine Sarcoma Treatment Introduction
12.3.4 General Electric Revenue in Uterine Sarcoma Treatment Business (2014-2019)
12.3.5 General Electric Recent Development
12.4 Koninklijke Philips
12.4.1 Koninklijke Philips Company Details
12.4.2 Company Description and Business Overview
12.4.3 Uterine Sarcoma Treatment Introduction
12.4.4 Koninklijke Philips Revenue in Uterine Sarcoma Treatment Business (2014-2019)
12.4.5 Koninklijke Philips Recent Development
12.5 Siemens Healthcare
12.5.1 Siemens Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Uterine Sarcoma Treatment Introduction
12.5.4 Siemens Healthcare Revenue in Uterine Sarcoma Treatment Business (2014-2019)
12.5.5 Siemens Healthcare Recent Development
12.6 Intas Pharmaceuticals
12.6.1 Intas Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Uterine Sarcoma Treatment Introduction
12.6.4 Intas Pharmaceuticals Revenue in Uterine Sarcoma Treatment Business (2014-2019)
12.6.5 Intas Pharmaceuticals Recent Development
12.7 Sun Pharmaceutical
12.7.1 Sun Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Uterine Sarcoma Treatment Introduction
12.7.4 Sun Pharmaceutical Revenue in Uterine Sarcoma Treatment Business (2014-2019)
12.7.5 Sun Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Uterine Sarcoma Treatment Key Market Segments
Table Key Players Uterine Sarcoma Treatment Covered
Table Global Uterine Sarcoma Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Uterine Sarcoma Treatment Market Size Market Share by Type 2014-2025
Figure Surgery Figures
Table Key Players of Surgery
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Hormone Therapy Figures
Table Key Players of Hormone Therapy
Table Global Uterine Sarcoma Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Uterine Sarcoma Treatment Report Years Considered
Table Global Uterine Sarcoma Treatment Market Size 2014-2025 (Million US$)
Figure Global Uterine Sarcoma Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Uterine Sarcoma Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Uterine Sarcoma Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Uterine Sarcoma Treatment Market Share by Regions 2014-2019
Figure Global Uterine Sarcoma Treatment Market Share by Regions 2014-2019
Figure Global Uterine Sarcoma Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Uterine Sarcoma Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Uterine Sarcoma Treatment Market Share by Manufacturers (2014-2019)
Figure Global Uterine Sarcoma Treatment Market Share by Manufacturers in 2018
Table Global Uterine Sarcoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Uterine Sarcoma Treatment Product/Solution/Service
Table Date of Enter into Uterine Sarcoma Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Uterine Sarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Uterine Sarcoma Treatment Market Size Share by Type (2014-2019)
Figure Global Uterine Sarcoma Treatment Market Size Market Share by Type (2014-2019)
Table Global Uterine Sarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Uterine Sarcoma Treatment Market Size Share by Application (2014-2019)
Figure Global Uterine Sarcoma Treatment Market Size Market Share by Application (2014-2019)
Figure Global Uterine Sarcoma Treatment Revenue Market Share by Application in 2018
Figure United States Uterine Sarcoma Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Uterine Sarcoma Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Uterine Sarcoma Treatment Market Share (2018-2019)
Table United States Uterine Sarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Uterine Sarcoma Treatment Market Share by Type (2014-2019)
Table United States Uterine Sarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Uterine Sarcoma Treatment Market Share by Application (2014-2019)
Figure Europe Uterine Sarcoma Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Uterine Sarcoma Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Uterine Sarcoma Treatment Market Share (2018-2019)
Table Europe Uterine Sarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Uterine Sarcoma Treatment Market Share by Type (2014-2019)
Table Europe Uterine Sarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Uterine Sarcoma Treatment Market Share by Application (2014-2019)
Figure China Uterine Sarcoma Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Uterine Sarcoma Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Uterine Sarcoma Treatment Market Share (2018-2019)
Table China Uterine Sarcoma Treatment Market Size by Type (2014-20189) (Million US$)
Table China Uterine Sarcoma Treatment Market Share by Type (2014-2019)
Table China Uterine Sarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table China Uterine Sarcoma Treatment Market Share by Application (2014-2019)
Figure Japan Uterine Sarcoma Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Uterine Sarcoma Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Uterine Sarcoma Treatment Market Share (2018-2019)
Table Japan Uterine Sarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Uterine Sarcoma Treatment Market Share by Type (2014-2019)
Table Japan Uterine Sarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Uterine Sarcoma Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Uterine Sarcoma Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Uterine Sarcoma Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Uterine Sarcoma Treatment Market Share (2018-2019)
Table Southeast Asia Uterine Sarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Uterine Sarcoma Treatment Market Share by Type (2014-2019)
Table Southeast Asia Uterine Sarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Uterine Sarcoma Treatment Market Share by Application (2014-2019)
Figure India Uterine Sarcoma Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Uterine Sarcoma Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Uterine Sarcoma Treatment Market Share (2018-2019)
Table India Uterine Sarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table India Uterine Sarcoma Treatment Market Share by Type (2014-2019)
Table India Uterine Sarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table India Uterine Sarcoma Treatment Market Share by Application (2014-2019)
Figure Central & South America Uterine Sarcoma Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Uterine Sarcoma Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Uterine Sarcoma Treatment Market Share (2018-2019)
Table Central & South America Uterine Sarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Uterine Sarcoma Treatment Market Share by Type (2014-2019)
Table Central & South America Uterine Sarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Uterine Sarcoma Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Uterine Sarcoma Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Uterine Sarcoma Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Uterine Sarcoma Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Uterine Sarcoma Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table General Electric Company Details
Table General Electric Revenue in Uterine Sarcoma Treatment Business (2014-2019)(Million US$)
Figure General Electric Revenue Growth Rate in Uterine Sarcoma Treatment Business (2014-2019)
Table General Electric Recent Development
Table Koninklijke Philips Company Details
Table Koninklijke Philips Revenue in Uterine Sarcoma Treatment Business (2014-2019)(Million US$)
Figure Koninklijke Philips Revenue Growth Rate in Uterine Sarcoma Treatment Business (2014-2019)
Table Koninklijke Philips Recent Development
Table Siemens Healthcare Company Details
Table Siemens Healthcare Revenue in Uterine Sarcoma Treatment Business (2014-2019)(Million US$)
Figure Siemens Healthcare Revenue Growth Rate in Uterine Sarcoma Treatment Business (2014-2019)
Table Siemens Healthcare Recent Development
Table Intas Pharmaceuticals Company Details
Table Intas Pharmaceuticals Revenue in Uterine Sarcoma Treatment Business (2014-2019)(Million US$)
Figure Intas Pharmaceuticals Revenue Growth Rate in Uterine Sarcoma Treatment Business (2014-2019)
Table Intas Pharmaceuticals Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Uterine Sarcoma Treatment Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Uterine Sarcoma Treatment Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Global Uterine Sarcoma Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Uterine Sarcoma Treatment Market Size Share by Regions (2019-2025)
Figure Global Uterine Sarcoma Treatment Market Size Share by Regions in 2025
Figure United States Uterine Sarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Uterine Sarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Uterine Sarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Uterine Sarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Uterine Sarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Uterine Sarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Uterine Sarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Uterine Sarcoma Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Uterine Sarcoma Treatment Market Size by Product (2019-2025)
Figure Global Uterine Sarcoma Treatment Market Size by Product in 2025
Table Global Uterine Sarcoma Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Uterine Sarcoma Treatment Market Size by Application (2019-2025)
Figure Global Uterine Sarcoma Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の子宮筋腫市場：市場規模・現状・予測
    Global Uterine Fibroids Market Size, Status and Forecast 2019-2025
    QYR9N8162 2019年6月14日 109Pages
    当資料は、子宮筋腫のグローバル市場について調査・分析したレポートで、種類別（非ホルモン治療、ホルモン治療）、用途別（病院、外来手術センター、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の子宮生検鉗子市場2019
    Global Uterine Biopsy Forceps Sales Market Report 2019
    QYR9N5400 2019年6月14日 102Pages
    本調査レポートでは、子宮生検鉗子の世界市場について調査・分析し、子宮生検鉗子のメーカー別販売量、市場シェア分析、種類別販売分析（使い捨て子宮生検鉗子、再利用可能な子宮生検鉗子）、用途別販売分析（病院、診療所、外来手術センター）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格...
  • 世界の子宮内避妊器具市場2019
    Global Intra-Uterine Contraceptive Devices Sales Market Report 2019
    QYR9N2025 2019年6月10日 120Pages
    本調査レポートでは、子宮内避妊器具の世界市場について調査・分析し、子宮内避妊器具のメーカー別販売量、市場シェア分析、種類別販売分析（銅IUD、ホルモン性IUD）、用途別販売分析（病院、婦人科クリニック、地域医療）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向...
  • 世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測
    Global Meningococcal Infections Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7541 2019年6月14日 94Pages
    当資料は、髄膜炎菌感染症の治療のグローバル市場について調査・分析したレポートで、種類別（抗生物質、グルココルチコイド、プロテインC濃縮物）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...
  • 世界の腱炎治療市場：市場規模・現状・予測
    Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8111 2019年6月14日 93Pages
    当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・腱炎治療...
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界のディンプル形成術の治療市場：市場規模・現状・予測
    Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7109 2019年6月14日 93Pages
    当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の副甲状腺機能低下症の治療市場：市場規模・現状・予測
    Global Hypoparathyroidism Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7330 2019年6月14日 99Pages
    当資料は、副甲状腺機能低下症の治療のグローバル市場について調査・分析したレポートで、種類別（経口、非経口）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    <...
  • 世界の精神神経疾患および治療市場：市場規模・現状・予測
    Global Neuropsychiatric Disorders And Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7660 2019年6月14日 97Pages
    当資料は、精神神経疾患および治療のグローバル市場について調査・分析したレポートで、種類別（変性疾患、神経障害、精神病）、用途別（病院、診療所、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の汗腺炎掻爬治療市場：市場規模・現状・予測
    Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7295 2019年6月14日 99Pages
    当資料は、汗腺炎掻爬治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・汗腺炎...
  • 世界の子宮筋腫市場：市場規模・現状・予測世界の子宮筋腫市場：市場規模・現状・予測 Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasional…
  • 世界の子宮生検鉗子市場2019世界の子宮生検鉗子市場2019 The global Uterine Biopsy Forceps market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Uterine Biopsy Forceps market status and forecast, categorizes the global Uterine Biopsy Forceps market size…
  • 世界の子宮内避妊器具市場2019世界の子宮内避妊器具市場2019 The global Intra-Uterine Contraceptive Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Intra-Uterine Contraceptive Devices market status and forecast, categorizes the global Intra-Ut…
  • 世界のうつ病治療市場：市場規模・現状・予測世界のうつ病治療市場：市場規模・現状・予測 Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest.One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the t…
  • 世界の転移性乳がんの治療市場：市場規模・現状・予測世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…